Add BrightSurf on Google Email

The Lancet


The Lancet: Without immediate action nearly 260 million people in the USA predicted to have overweight or obesity by 2050

The Lancet predicts devastating trends at the population level, with 43.1 million US children and adolescents and 213 million adults expected to have overweight or obesity by 2050. Without significant reform, the prevalence of overweight and obesity is set to continue and even increase in some states.

SourceThe Lancet·JournalThe Lancet·TypeComputational simulation/modeling·DateNov 14, 2024

The Lancet: Health threats of climate change reach record-breaking levels, as experts call for trillions of dollars spent on fossil fuels to be redirected towards protecting people’s health, lives and livelihoods

The Lancet's Countdown report reveals record-breaking human costs of climate change, including heat-related deaths increasing by 167% globally in 2023. The report calls for trillions of dollars spent on fossil fuels to be redirected towards protecting people's health and lives.

SourceThe Lancet·JournalThe Lancet·TypeData/statistical analysis·DateOct 29, 2024

The Lancet Public Health: New Commission calls for regulatory reform to tackle the health impacts of the rapid global expansion of commercial gambling

Commercial gambling poses a threat to public health, with 448.7 million adults worldwide experiencing risk gambling and 80 million experiencing gambling disorder. The new Commission report calls for increased regulation to tackle these harms, particularly among children and adolescents.

SourceThe Lancet·JournalThe Lancet Public Health·TypeLiterature review·DateOct 24, 2024

The Lancet Public Health: Accelerating actions to eliminate tobacco smoking could help increase life expectancy and prevent millions of premature deaths by 2050, modelling study suggests

A modelling study suggests that reducing tobacco smoking globally to 5% by 2050 could increase life expectancy and prevent millions of premature deaths. Accelerating actions to eliminate tobacco smoking could result in up to 1.5 additional years of life expectancy among males and 0.4 years among females.

SourceThe Lancet·JournalThe Lancet Public Health·TypeComputational simulation/modeling·DateOct 2, 2024

The Lancet Public Health: Banning tobacco sales among young people could prevent 1.2 million lung cancer deaths, global modelling study suggests

A new study suggests that banning the purchase of cigarettes and other tobacco products among people born between 2006 and 2010 could prevent an estimated 1.2 million lung cancer deaths in 185 countries by 2095. This could reduce the impact of smoking on lung cancer deaths in future generations.

SourceThe Lancet·JournalThe Lancet Public Health·TypeComputational simulation/modeling·DateOct 2, 2024

The Lancet Public Health: MMR vaccine remains the best protection against measles - modelling study in England suggests level of protection decreases slightly over time

A modelling study suggests that slow waning of MMR vaccine-induced immunity may contribute to rising measles cases in double-vaccinated people. However, the MMR vaccine remains the most effective measure to prevent measles infection, and community vaccination levels above 95% are essential to prevent outbreaks.

SourceThe Lancet·JournalThe Lancet Public Health·TypeComputational simulation/modeling·DateSep 26, 2024

The Lancet Neurology: Air pollution, high temperatures, and metabolic risk factors driving global increases in stroke, with latest figures estimating 12 million cases and over 7 million deaths from stroke each year

The global stroke burden has increased significantly over the past three decades, driven by rising levels of air pollution, high temperatures, and metabolic risk factors. The study found that the number of people experiencing new strokes rose to 11.9 million in 2021, with an additional 93.8 million survivors and 7.3 million deaths.

SourceThe Lancet·JournalThe Lancet Neurology·TypeComputational simulation/modeling·DateSep 18, 2024

The Lancet: More than 39 million deaths from antibiotic-resistant infections estimated between now and 2050, suggests first global analysis

A new study estimates that more than 1 million people died each year due to antibiotic-resistant infections between 1990 and 2021. The study predicts that this number could increase to nearly 2 million by 2050, with a significant age-related shift in the impact of AMR on children under five years old.

SourceThe Lancet·JournalThe Lancet·TypeObservational study·DateSep 16, 2024

The Lancet: Managing early stages of abortion care at home after 12 weeks of pregnancy is safe and reduces time spent in hospital, study finds

A randomized controlled trial found that administering the first dose of misoprostol at home reduces hospital stay time by 71% and improves patient satisfaction. Women who took misoprostol at home also reported feeling more autonomous during a stressful process.

SourceThe Lancet·JournalThe Lancet·TypeRandomized controlled/clinical trial·DateAug 29, 2024

The Lancet Public Health: Climate change and ageing populations to drive greater disparities in deaths from hot and cold temperatures across Europe, modelling study suggests

A new study suggests that climate change and ageing populations will widen regional disparities in death risk from hot and cold temperatures in Europe. By 2100, heat-related deaths are projected to increase significantly, mostly in southern regions, while cold-related deaths are expected to decline slightly.

SourceThe Lancet·JournalThe Lancet Public Health·TypeComputational simulation/modeling·DateAug 21, 2024

The Lancet: Nearly half of dementia cases could be prevented or delayed by tackling 14 risk factors starting in childhood, including two new risks—high cholesterol and vision loss

The Lancet Commission on dementia prevention recommends addressing 14 modifiable risk factors to prevent or delay nearly half of dementia cases. The report identifies two new risks: high LDL cholesterol and vision loss, which are associated with 9% of all dementia cases.

SourceThe Lancet·JournalThe Lancet·TypeLiterature review·DateJul 31, 2024

The Lancet Psychiatry: One in six people who stop antidepressants will experience discontinuation symptoms as a direct result, finds most comprehensive study to date

A systematic review and meta-analysis of over 20,000 patients found that one in six to seven patients will experience discontinuation symptoms directly caused by stopping the medication. Severe symptoms occurred in about 3% of patients, with certain antidepressants increasing the risk.

SourceThe Lancet·JournalThe Lancet Psychiatry·TypeMeta-analysis·DateJun 5, 2024

The Lancet: 750,000 deaths linked to antimicrobial resistance could be prevented every year through available vaccines, water and sanitation, and infection control methods

A new Lancet Series estimates that over 750,000 deaths associated with antimicrobial resistance (AMR) could be prevented annually through improved prevention methods. AMR poses significant threats to newborns, elderly individuals, and those with chronic illnesses, causing nearly 5 million deaths globally each year.

SourceThe Lancet·JournalThe Lancet·TypeComputational simulation/modeling·DateMay 23, 2024

The Lancet Public Health: Global study reveals stark differences between females and males in major causes of disease burden, underscoring the need for gender-responsive approaches to health

A new study examining disparities in the 20 leading causes of disease burden between females and males found that non-fatal conditions like musculoskeletal conditions and mental health conditions disproportionately affect females globally. In contrast, males are disproportionately affected by conditions leading to premature death, such...

SourceThe Lancet·JournalThe Lancet Public Health·TypeComputational simulation/modeling·DateMay 1, 2024

The Lancet: Many people with breast cancer ‘systematically left behind’ due to inaction on inequities and hidden suffering

A new Lancet Commission reveals that many people with breast cancer are being systematically left behind due to inaction on inequities and hidden suffering. The commission highlights the need for better patient support, including improved communication between patients and healthcare professionals.

SourceThe Lancet·JournalThe Lancet·TypeLiterature review·DateApr 15, 2024

The Lancet Neurology: Neurological conditions now leading cause of ill health and disability globally, affecting 3.4 billion people worldwide

The study reveals that neurological conditions are the leading cause of ill health and disability globally, with 3.4 billion people affected in 2021. The analysis shows a significant increase in disability-adjusted life years (DALYs) caused by these conditions over the past three decades.

SourceThe Lancet·JournalThe Lancet Neurology·TypeComputational simulation/modeling·DateMar 14, 2024

The Lancet: Black women in the USA were murdered six times more often than White women between 1999 and 2020, state-level analysis indicates

A recent analysis found that Black women in the USA have significantly higher homicide rates compared to their White peers, with disparities increasing from 1999 to 2020. Gun deaths among Black and White women also increased, with Black women being more likely to be killed by firearms.

SourceThe Lancet·JournalThe Lancet·TypeObservational study·DateFeb 8, 2024

The Lancet Public Health: Transgender, non-binary, and gender diverse people more likely to have a long-term mental health condition, first England-wide study suggests

A recent English study found that transgender men and women are at a higher risk of long-term mental health conditions (16.4% and 15.9%, respectively), while non-binary individuals face an even higher risk (47.2%). The study also highlights the need for improved support systems and staff training to address these disparities.

SourceThe Lancet·JournalThe Lancet Public Health·TypeObservational study·DateJan 31, 2024

The Lancet Child & Adolescent Health: Paediatric care for non-White children is universally worse across the USA; policy reform urgently needed to address disparities

Inequities in pediatric care span broad specialties and systems, including neonatal, emergency, palliative, and mental health care. Policy reforms are crucial to address deep-rooted structural racism and disparities in housing, employment, insurance, and the criminal justice system.

SourceThe Lancet·JournalThe Lancet Child & Adolescent Health·TypeLiterature review·DateJan 17, 2024

The Lancet Psychiatry: Mental health care and research must directly confront systemic racism to improve the health and lives of Black Americans

Research highlights the role of racism in producing mental health disparities among Black Americans, calling for community-driven action to reduce inequitable care. The study's findings emphasize the need to address systemic racism as a root cause of poor mental health outcomes.

SourceThe Lancet·JournalThe Lancet Psychiatry·TypeLiterature review·DateDec 13, 2023

The Lancet Oncology: Risk of dying from cancer in some poorer districts of England over 70% higher than wealthy districts, study suggests

A recent study published in The Lancet Oncology found that the risk of dying from cancer in some poorer districts of England is over 70% higher than in wealthier areas. The study used death records to estimate the risk of dying from various cancers in each district, highlighting significant inequalities in cancer mortality across diffe...

SourceThe Lancet·JournalThe Lancet Oncology·TypeObservational study·DateDec 11, 2023

The Lancet: Deferred clamping of umbilical cord reduces risk of death in premature babies by at least a third, suggest two studies with the most comprehensive analysis to date

Two systematic reviews and meta-analyses found that delaying umbilical cord clamping by at least two minutes can reduce the risk of death in premature babies. The studies included over 10,000 babies from 60 studies and showed a significant reduction in mortality rates for deferred clamping compared to immediate clamping.

SourceThe Lancet·JournalThe Lancet·TypeMeta-analysis·DateNov 14, 2023

THE LANCET NEUROLOGY: Stroke could cause nearly 10 million deaths annually by 2050, mostly in LMICs, and cost up to US$2 trillion per year, new report warns

The number of people who die from stroke globally is projected to increase by 50% to 9.7 million deaths per year by 2050, mainly affecting Low-Middle Income Countries (LMICs). The annual costs are estimated to reach up to US$2.3 trillion, with a disproportionate impact on LMICs.

SourceThe Lancet·JournalThe Lancet Neurology·TypeSystematic review·DateOct 9, 2023

THE LANCET PLANETARY HEALTH: Cardiovascular disease deaths and IQ loss caused by lead exposure far higher than previous estimates, global study indicates

A global study estimates that lead exposure causes 5.5 million cardiovascular deaths and loses 765 million IQ points in children under five years old annually. The economic cost of lead exposure is estimated to be $6 trillion, with the majority attributed to cardiovascular disease deaths.

SourceThe Lancet·JournalThe Lancet Planetary Health·TypeComputational simulation/modeling·DateSep 11, 2023

THE LANCET PLANETARY HEALTH: Experts warn 'green growth' in high income countries is not happening, call for 'post-growth' climate policies to meet Paris targets

A study found that high-income countries' emission reductions fall short of Paris Agreement targets, with many needing to reduce emissions by 30 times faster than achieved. Experts call for a post-growth approach to decarbonize and achieve urgent social and ecological goals.

SourceThe Lancet·JournalThe Lancet Planetary Health·DateSep 4, 2023

THE LANCET: Levonorgestrel emergency contraceptive pill is more effective when taken with an anti-inflammatory medication, study suggests

A recent study published in The Lancet found that taking levonorgestrel emergency contraceptive pills with an anti-inflammatory medication called piroxicam significantly prevents more pregnancies compared to taking levonorgestrel alone. The co-treatment increased the pill's efficacy by up to 32%.

SourceThe Lancet·JournalThe Lancet·TypeRandomized controlled/clinical trial·DateAug 16, 2023

THE LANCET ONCOLOGY: First randomised trial finds AI-supported mammography screening is safe and almost halved radiologist workload

A randomized trial involving over 80,000 Swedish women found AI-supported mammography analysis to be as accurate as two breast radiologists working together in detecting breast cancer. The technology also reduced the screen-reading workload by nearly half without increasing false positives.

SourceThe Lancet·JournalThe Lancet Oncology·TypeRandomized controlled/clinical trial·DateAug 1, 2023

The Lancet: People on ART with low but detectible levels of HIV viral load have almost zero risk of sexually transmitting the virus to others, in-depth review suggests

A systematic review of eight studies found that people living with HIV and maintaining low viral loads have almost zero risk of transmitting the virus to their sexual partners. The findings support the use of simpler testing approaches and promote the expansion of alternative viral load testing modalities in resource-limited settings.

SourceThe Lancet·JournalThe Lancet·TypeSystematic review·DateJul 22, 2023

THE LANCET HEALTHY LONGEVITY: Razor-sharp memory function in older adults linked to faster movement and better mental health, study suggests

A new study published in The Lancet Healthy Longevity journal found that superagers, individuals with razor-sharp memory function, have faster movement speed and better mental health compared to typical older adults. They also tend to have lower rates of anxiety and depression.

SourceThe Lancet·JournalThe Lancet Healthy Longevity·TypeObservational study·DateJul 13, 2023

THE LANCET HAEMATOLOGY: Experts urge governments to take immediate actions to provide basic levels of care for people with sickle cell disease, as recent study suggests global mortality burden is nearly 11 times higher than recorded

A recent study suggests that the global mortality burden of Sickle Cell Disease (SCD) is approximately 11 times higher than previously recorded, with an estimated 376,000 deaths in 2021. The Commission highlights the need for increased funding and access to treatments such as hydroxyurea, blood transfusions, and malaria prevention meth...

SourceThe Lancet·JournalThe Lancet Haematology·DateJul 11, 2023

THE LANCET and THE LANCET DIABETES & ENDOCRINOLOGY: “Cascade of widening inequity” accelerating the global diabetes crisis

The global diabetes crisis is accelerating due to widening inequity, with structural racism and geographic disparities exacerbating the problem. The new Series projects that over 1.3 billion people will live with diabetes by 2050, with marginalized communities facing reduced access to care and worse health outcomes.

SourceThe Lancet·JournalThe Lancet·TypeSystematic review·DateJun 22, 2023

THE LANCET CHILD & ADOLESCENT HEALTH: Prolonged rise in eating disorders and self-harm among adolescent girls in the UK following the COVID-19 pandemic, best evidence to date suggests

A nationwide study in the UK found a significant rise in eating disorders and self-harm among adolescent girls between March 2020 and March 2022. The rate of eating disorder diagnoses was 42% higher than expected, with 3,862 observed cases compared to 2,713 projected cases.

SourceThe Lancet·JournalThe Lancet Child & Adolescent Health·TypeMeta-analysis·DateJun 20, 2023

THE LANCET: First phase 3 trial of a chikungunya vaccine candidate finds it is generally safe and provokes an immune response

A phase 3 trial found that the VLA1553 vaccine candidate produced an immune response in 99% of participants, inducing protection against disease. The study also showed that the vaccine was generally safe and well-tolerated across all age groups, with most adverse events being mild or moderate.

SourceThe Lancet·JournalThe Lancet·TypeRandomized controlled/clinical trial·DateJun 12, 2023

THE LANCET INFECTIOUS DISEASES: Taking a common diabetes medication after testing positive for SARS-CoV-2 reduces risk of developing long COVID by 40%, study finds

A new randomized controlled trial found that taking metformin after testing positive for SARS-CoV-2 reduces the risk of developing long COVID by 40%. The study, published in The Lancet Infectious Diseases, involved over 1,100 patients and showed metformin prevented over 40% of cases of long COVID over a 10-month follow-up period.

SourceThe Lancet·JournalThe Lancet Infectious Diseases·TypeRandomized controlled/clinical trial·DateJun 8, 2023

THE LANCET PUB. HEALTH: Mailing at-home HPV sampling kits nearly doubles cervical screening uptake among hard-to-reach populations, US clinical trial suggests

A US-based clinical trial found that mailing high-risk human papillomavirus (hrHPV) sampling kits to low-income, under-screened women increased cervical cancer screening uptake by nearly double. The study used intensive community outreach campaigns and mailed HPV kits with effective help scheduling in-person appointments.

SourceThe Lancet·JournalThe Lancet Public Health·TypeRandomized controlled/clinical trial·DateMay 11, 2023